title: DPP-4 inhibitors and angioedema: a cause for concern?
authors.affiliation: Department of Pharmacy, University of Mississippi Medical Center, Jackson, USA.
authors.forename: Jennifer S
authors.initials: JS
authors.lastname: Byrd
authors.forename: Deborah S
authors.initials: DS
authors.lastname: Minor
authors.forename: Raghda
authors.initials: R
authors.lastname: Elsayed
authors.forename: Gailen D
authors.initials: GD
authors.lastname: Marshall
mesh_terms: D000799:Angioedema / Q000139:chemically induced* / Q000209:etiology / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D001920:Bradykinin / Q000378:metabolism; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D011358:Product Surveillance, Postmarketing; D013373:Substance P / Q000378:metabolism
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D054873:Dipeptidyl-Peptidase IV Inhibitors; D013373:Substance P; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D001920:Bradykinin